NU Skin Enterprises, Inc.: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 6, 2020 and accepted by EDGAR at Aug 5, 2020, 21:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $612.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-01-01 to 2020-06-30 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-04-01 to 2020-06-30 | $154.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-01-01 to 2020-06-30 | $279.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-04-01 to 2020-06-30 | $458.3m | us-gaap:GrossProfit |
| Gross profit | 6 months2020-01-01 to 2020-06-30 | $850.5m | us-gaap:GrossProfit |
| Operating income | 3 months2020-04-01 to 2020-06-30 | $58.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-01-01 to 2020-06-30 | $94.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-04-01 to 2020-06-30 | $17.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-01-01 to 2020-06-30 | $28.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | $41.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-01-01 to 2020-06-30 | $61.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-01-01 to 2020-06-30 | $1.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-04-01 to 2020-06-30 | $0.81 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-01-01 to 2020-06-30 | $1.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-04-01 to 2020-06-30 | 51,925,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-01-01 to 2020-06-30 | 53,502,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-01-01 to 2020-06-30 | $166.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-04-01 to 2020-06-30 | $9.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2020-01-01 to 2020-06-30 | $28.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2020-01-01 to 2020-06-30 | $40.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2020-01-01 to 2020-06-30 | $107.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-06-30 | $375.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $785.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $1.79bn | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $484.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $1.00bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-06-30 | $319.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-06-30 | $95.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-06-30 | $792.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001140361-20-017594. Last ingested by Listed: Nov 5, 2026, 18:30 ET. Listed shows no prices and gives no investment advice.